![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Completed |
Unique ID issued by UMIN | UMIN000003777 |
Receipt No. | R000004573 |
Scientific Title | Study to evaluate what patients basline factors affect placebo effect in patients with insomnia |
Date of disclosure of the study information | 2010/06/18 |
Last modified on | 2011/06/20 |
Basic information | ||
Public title | Study to evaluate what patients basline factors affect placebo effect in patients with insomnia | |
Acronym | Study to evaluate what patients basline factors affect placebo effect in patients with insomnia | |
Scientific Title | Study to evaluate what patients basline factors affect placebo effect in patients with insomnia | |
Scientific Title:Acronym | Study to evaluate what patients basline factors affect placebo effect in patients with insomnia | |
Region |
|
Condition | ||
Condition | Insomnia | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To examine what patients' baseline factors affect the placebo effect using the database for placebo groups of a clinical study in patients with insomnia |
Basic objectives2 | Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | Exploratory |
Trial characteristics_2 | |
Developmental phase | Not applicable |
Assessment | |
Primary outcomes | Change in subjective sleep latency |
Key secondary outcomes |
Base | |
Study type | Interventional |
Study design | |
Basic design | Single arm |
Randomization | Randomized |
Randomization unit | |
Blinding | Double blind -all involved are blinded |
Control | Placebo |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 1 | |
Purpose of intervention | Treatment | |
Type of intervention |
|
|
Interventions/Control_1 | Placebo (the database only from placebo groups will be used for the current study) | |
Interventions/Control_2 | ||
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | All the patients randominzed in placebo group in the clinical study in patients with primary insomnia | |||
Key exclusion criteria | Patients who were not included in FAS were excluded | |||
Target sample size | 380 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Graduate School of Medicine and Public Health, Kyoto University | ||||||
Division name | Department of Pharmacoepidemiology | ||||||
Zip code | |||||||
Address | Yoshida Konoe-cho, Sakyo-ku Kyoto 606-8501, Japan | ||||||
TEL | |||||||
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Graduate School of Medicine and Public Health, Kyoto University | ||||||
Division name | Department of Pharmacoepidemiology | ||||||
Zip code | |||||||
Address | |||||||
TEL | |||||||
Homepage URL | |||||||
ogawa.atsushi@fx7.ecs.kyoto-u.ac.jp |
Sponsor | |
Institute | Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University |
Institute | |
Department |
Funding Source | |
Organization | None |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Published |
Result | |
URL related to results and publications | http://www.sciencedirect.com/science/article/pii/S1389945711001250 |
Number of participants that the trial has enrolled | |
Results | Ogawa A, Hinotsu S, Urushihara H, Kawakami K. Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration. Sleep Med 2011;6:565-571 |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Completed | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date | |||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
|
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004573 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |